The FDA has approved Savient Pharmaceuticals' experimental drug therapy for breast cancer. Savient said that Soltamox is the first oral liquid form of tamoxifen. It has already been approved in several European countries. Savient expects to line up a marketing partner in early 2006.
- read this AP report for more information